Monitoring of transmitter metabolites by voltammetry in cerebrospinal fluid following neural pathway stimulation.

Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine.

Cerebrospinal fluid production: stimulation by cholera toxin.

Cerebrospinal fluid amine metabolites in acute schizophrenia.

Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure.

MS Analysis of Cerebrospinal Fluid Metabolites in the Pterin Biosynthetic Pathway.

Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid.

Vancomycin therapeutic drug monitoring in cerebrospinal fluid.

Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Concentrations of cerebrospinal fluid monoamine metabolites in suicides.

Cerebrospinal Fluid Levels of Monoamine Metabolites in the Epileptic Baboon.

Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

Cerebrospinal-fluid concentration of diazepam and its metabolites in man.

Perioperative continuous cerebrospinal fluid pressure monitoring in patients with spontaneous cerebrospinal fluid leaks.

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients.

The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography.

Stimulation of transmitter release by guanidine derivatives.

Embryonic cerebrospinal fluid in brain development: neural progenitor control.

Enrichment of metabolites in the cerebrospinal fluid of cod (Gadus morhua) following oral administration of hexachlorobenzene and 2,4',5-trichlorobiphenyl.

Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage.

The cerebrospinal fluid as a pathway in neuroendocrine integration.

Measurement of prostaglandin F2alpha in human cerebrospinal fluid by single ion monitoring.

Cerebrospinal fluid ferritin--unspecific and unsuitable for disease monitoring.

Intraparenchymal intracranial pressure monitoring for hydrocephalus and cerebrospinal fluid disorders.

[Astroprotein in cerebrospinal fluid following experimental brain injury (author's transl)].

Suggest Documents

Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine.

Cerebrospinal fluid production: stimulation by cholera toxin.

Cerebrospinal fluid amine metabolites in acute schizophrenia.

Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure.

MS Analysis of Cerebrospinal Fluid Metabolites in the Pterin Biosynthetic Pathway.

Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid.

Vancomycin therapeutic drug monitoring in cerebrospinal fluid.

Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Concentrations of cerebrospinal fluid monoamine metabolites in suicides.

Cerebrospinal Fluid Levels of Monoamine Metabolites in the Epileptic Baboon.

Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

Cerebrospinal-fluid concentration of diazepam and its metabolites in man.

Perioperative continuous cerebrospinal fluid pressure monitoring in patients with spontaneous cerebrospinal fluid leaks.

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients.

The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography.

Stimulation of transmitter release by guanidine derivatives.

Embryonic cerebrospinal fluid in brain development: neural progenitor control.

Enrichment of metabolites in the cerebrospinal fluid of cod (Gadus morhua) following oral administration of hexachlorobenzene and 2,4',5-trichlorobiphenyl.

Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage.

The cerebrospinal fluid as a pathway in neuroendocrine integration.

Measurement of prostaglandin F2alpha in human cerebrospinal fluid by single ion monitoring.

Cerebrospinal fluid ferritin--unspecific and unsuitable for disease monitoring.

Intraparenchymal intracranial pressure monitoring for hydrocephalus and cerebrospinal fluid disorders.

[Astroprotein in cerebrospinal fluid following experimental brain injury (author's transl)].

Monitoring of transmitter metabolites by voltammetry in cerebrospinal fluid following neural pathway stimulation.

Recommend Documents

Follow Us